Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion type Assertion NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_head.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion description "[PEG-IFN-alfa 2b 1.5 microg/kg once weekly is the optimal dosing frequency for patients with chronic hepatitis C with predominantly genotype 1 infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_provenance.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion evidence source_evidence_literature NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_provenance.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion SIO_000772 15952104 NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_provenance.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion wasDerivedFrom befree-2016 NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_provenance.
- NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_assertion wasGeneratedBy ECO_0000203 NP499164.RAWJ1Fzj--bZLBPqdGQ64NVm3Uu3XZylZZ1I8VHxmuYdQ130_provenance.